These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

661 related items for PubMed ID: 16459077

  • 1. Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
    Nishimori I, Vullo D, Minakuchi T, Morimoto K, Onishi S, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2006 Apr 15; 16(8):2182-8. PubMed ID: 16459077
    [Abstract] [Full Text] [Related]

  • 2. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
    Nishimori I, Minakuchi T, Morimoto K, Sano S, Onishi S, Takeuchi H, Vullo D, Scozzafava A, Supuran CT.
    J Med Chem; 2006 Mar 23; 49(6):2117-26. PubMed ID: 16539401
    [Abstract] [Full Text] [Related]

  • 3. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
    Vullo D, Voipio J, Innocenti A, Rivera C, Ranki H, Scozzafava A, Kaila K, Supuran CT.
    Bioorg Med Chem Lett; 2005 Feb 15; 15(4):971-6. PubMed ID: 15686895
    [Abstract] [Full Text] [Related]

  • 4. Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.
    Nishimori I, Minakuchi T, Vullo D, Scozzafava A, Innocenti A, Supuran CT.
    J Med Chem; 2009 May 14; 52(9):3116-20. PubMed ID: 19338333
    [Abstract] [Full Text] [Related]

  • 5. Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
    Nishimori I, Minakuchi T, Onishi S, Vullo D, Scozzafava A, Supuran CT.
    J Med Chem; 2007 Jan 25; 50(2):381-8. PubMed ID: 17228881
    [Abstract] [Full Text] [Related]

  • 6. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
    Vullo D, Innocenti A, Nishimori I, Pastorek J, Scozzafava A, Pastoreková S, Supuran CT.
    Bioorg Med Chem Lett; 2005 Feb 15; 15(4):963-9. PubMed ID: 15686894
    [Abstract] [Full Text] [Related]

  • 7. Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides.
    Bertucci A, Innocenti A, Zoccola D, Scozzafava A, Tambutté S, Supuran CT.
    Bioorg Med Chem; 2009 Jul 15; 17(14):5054-8. PubMed ID: 19520577
    [Abstract] [Full Text] [Related]

  • 8. Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.
    Nishimori I, Vullo D, Innocenti A, Scozzafava A, Mastrolorenzo A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Sep 01; 15(17):3828-33. PubMed ID: 16039848
    [Abstract] [Full Text] [Related]

  • 9. Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates.
    Isik S, Kockar F, Aydin M, Arslan O, Guler OO, Innocenti A, Scozzafava A, Supuran CT.
    Bioorg Med Chem; 2009 Feb 01; 17(3):1158-63. PubMed ID: 19124253
    [Abstract] [Full Text] [Related]

  • 10. Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides.
    Nishimori I, Minakuchi T, Onishi S, Vullo D, Cecchi A, Scozzafava A, Supuran CT.
    Bioorg Med Chem; 2007 Dec 01; 15(23):7229-36. PubMed ID: 17826101
    [Abstract] [Full Text] [Related]

  • 11. Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
    Nishimori I, Minakuchi T, Kohsaki T, Onishi S, Takeuchi H, Vullo D, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2007 Jul 01; 17(13):3585-94. PubMed ID: 17482815
    [Abstract] [Full Text] [Related]

  • 12. Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.
    Minakuchi T, Nishimori I, Vullo D, Scozzafava A, Supuran CT.
    J Med Chem; 2009 Apr 23; 52(8):2226-32. PubMed ID: 19317447
    [Abstract] [Full Text] [Related]

  • 13. Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides.
    Innocenti A, Firnges MA, Antel J, Wurl M, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Feb 15; 15(4):1149-54. PubMed ID: 15686931
    [Abstract] [Full Text] [Related]

  • 14. Purification and inhibition studies with anions and sulfonamides of an α-carbonic anhydrase from the Antarctic seal Leptonychotes weddellii.
    Cincinelli A, Martellini T, Innocenti A, Scozzafava A, Supuran CT.
    Bioorg Med Chem; 2011 Mar 15; 19(6):1847-51. PubMed ID: 21377369
    [Abstract] [Full Text] [Related]

  • 15. Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides.
    Zimmerman S, Innocenti A, Casini A, Ferry JG, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2004 Dec 20; 14(24):6001-6. PubMed ID: 15546717
    [Abstract] [Full Text] [Related]

  • 16. Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides.
    Ozensoy O, Nishimori I, Vullo D, Puccetti L, Scozzafava A, Supuran CT.
    Bioorg Med Chem; 2005 Nov 15; 13(22):6089-93. PubMed ID: 16006130
    [Abstract] [Full Text] [Related]

  • 17. Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c.
    Carta F, Maresca A, Covarrubias AS, Mowbray SL, Jones TA, Supuran CT.
    Bioorg Med Chem Lett; 2009 Dec 01; 19(23):6649-54. PubMed ID: 19846301
    [Abstract] [Full Text] [Related]

  • 18. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety.
    Sethi KK, Vullo D, Verma SM, Tanç M, Carta F, Supuran CT.
    Bioorg Med Chem; 2013 Oct 01; 21(19):5973-82. PubMed ID: 23965175
    [Abstract] [Full Text] [Related]

  • 19. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F, Innocenti A, Sławiński J, Kornicka A, Brzozowski Z, Pomarnacka E, Scozzafava A, Temperini C, Supuran CT.
    Bioorg Med Chem; 2008 Apr 01; 16(7):3933-40. PubMed ID: 18242998
    [Abstract] [Full Text] [Related]

  • 20. Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.
    Nishimori I, Vullo D, Innocenti A, Scozzafava A, Mastrolorenzo A, Supuran CT.
    J Med Chem; 2005 Dec 01; 48(24):7860-6. PubMed ID: 16302824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.